Address |
Kagurazaka AK Building, 6/F Tokyo Tokyo 162 Japan |
Employees | - |
Website | http://www.eps-holdings.co.jp |
Updated | 07/08/2019 |
EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin and Others. The CRO segment offers clinical trials, data management, and statistical analysis. |